Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta
Conclusion These results suggest that CQ, alone or as an adjuvant therapeutic, could be used to inhibit the GBM malignant phenotype and could benefit GBM afflicted patients.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Drugs & Pharmacology | Investigational New Drugs | Neurology | Study